Because the AKT and mTOR signaling pathways have been widely reported to be associated with cancer-cell growth, an increase in AMPK accompanied with a reduction in AKT and mTOR would no doubt inhibit cell growth and the anchorage-independent growth capacities of ovarian cancer cells. This evidence concerns the gene PRKAA2 and cancer.